OraSure Technologies, Inc. (OSUR) News
Filter OSUR News Items
OSUR News Results
|Loading, please wait...|
OSUR News Highlights
- For OSUR, its 30 day story count is now at 2.
- Over the past 8 days, the trend for OSUR's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest OSUR News From Around the Web
Below are the latest news stories about Orasure Technologies Inc that investors may wish to consider to help them evaluate OSUR as an investment opportunity.
OraSure Technologies, Inc.'s (NASDAQ:OSUR) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
OraSure Technologies' (NASDAQ:OSUR) stock is up by a considerable 12% over the past three months. However, we wonder if...
Scott Gleason, SVP, Investor Relations and Corporate Communications, Will Serve as Interim CFOBETHLEHEM, Pa., Sept. 02, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care testing and sample collection technologies, announced that Chief Financial Officer Roberto Cuca has resigned from the Company effective September 17, 2021. The Company has initiated a search for a permanent Chief Financial Officer with the capabilities and qualifications to supp
Major HIV diagnostics market players include OraSure Technologies, Chembio Diagnostics, Abbott Laboratories, Cepheid, BD, BIONEER CORPORATION, Omega Diagnostics, Roche, Qiagen and Biomerieux.
Image source: The Motley Fool. Orasure Technologies Inc (NASDAQ: OSUR)Q2 2021 Earnings CallAug 3, 2021, 5:00 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorWelcome to the OraSure Technologies Incorporated 2021 Second Quarter Earnings Conference Call.
Earnings results for OraSure Technologies , Analyst Opinion on OraSure Technologies , Earnings and Valuation of (NASDAQ:OSUR), Stock market Insights & financial analysis, Best stock to invest, Investment Idea, The post Should you short it before the Earnings result? : OraSure Technologies (NASDAQ:OSUR) appeared first on .
OraSure Technologies Reports 2Q21 Revenue of $57.6 Million Driven by Strong Rebound in Core Business
Excluding COVID-19 product revenues, revenues for the second quarter grew 122% YoY and 48% sequentially as the Company''s core business began to return to pre-pandemic revenue levels Company received three Emergency Use Authorizations (EUAs) from the U.S. Food and Drug Administration (FDA) for its InteliSwab COVID-19 Rapid Tests for Non-Prescription (OTC), Professional Point-of-Care and Prescription Home Use Management to Host Analyst/Investor Call and Webcast Today at 5:00 p.m. ET BETHLEHEM, Pa., Aug. 03, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced its financial results for the three months ended June 30, 2021. "Th...
OraSure (OSUR) delivered earnings and revenue surprises of -150.00% and 1.96%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Rep. Susan Wild plans to promote the Lehigh Valley''s manufacturing sector to President Joe Biden, particularly the work being done by OraSure Technologies in Bethlehem.
OraSure (OSUR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OraSure Technologies, Inc. to Hold 2021 Second Quarter Earnings Conference Call Tuesday, August 3, 2021, 5:00 p.m. ET
BETHLEHEM, Pa., July 27, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2021 second quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Tuesday, August 3, 2021.